[AREDS and age-related macular degeneration].
Asensio Sánchez
V M
VM
D017668:Age of Onset; D000368:Aged; D000375:Aging / Q000473:pathology*; D000975:Antioxidants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018450:Disease Progression; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D008875:Middle Aged; D009316:National Institutes of Health (U.S.); D009974:Orthomolecular Therapy / Q000009:adverse effects; D014481:United States; D014810:Vitamin E / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015032:Zinc / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D019207:beta Carotene / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000975:Antioxidants; D019207:beta Carotene; D014810:Vitamin E; D015032:Zinc; D001205:Ascorbic Acid